Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 63.62% | 1.86% | 18.71% | 37.35% | 4.79% |
| Total Depreciation and Amortization | 3.44% | 8.84% | 8.38% | 6.11% | 2.85% |
| Total Amortization of Deferred Charges | 998.55% | -85.98% | -85.98% | -85.98% | -85.98% |
| Total Other Non-Cash Items | -254.06% | 78.10% | -102.67% | -249.04% | 49.29% |
| Change in Net Operating Assets | 9.84% | 1,263.57% | 1,036.38% | 692.10% | 953.71% |
| Cash from Operations | 192.90% | 195.54% | 168.99% | 75.07% | 71.70% |
| Capital Expenditure | -140.73% | -86.36% | -34.45% | 46.58% | 55.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -594.22% | -12,366.75% | -29,383.13% | -3,663.54% | -4,274.85% |
| Cash from Investing | -562.85% | -4,838.10% | -6,770.48% | -1,048.55% | -461.75% |
| Total Debt Issued | -21.81% | -37.26% | 4.86% | 698.64% | 416.02% |
| Total Debt Repaid | 0.79% | -1.11% | -10.65% | -20.17% | -31.06% |
| Issuance of Common Stock | 16.60% | 417.27% | 417.27% | 87.50% | -- |
| Repurchase of Common Stock | 85.24% | 85.24% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.67% | -582.32% | 35.29% | 104.94% | -107.74% |
| Cash from Financing | 7.54% | 252.53% | 339.21% | 465.98% | 7,137.12% |
| Foreign Exchange rate Adjustments | -411.31% | -13.76% | 108.55% | 97.17% | 126.31% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | -200.00% | 0.00% | -- |
| Net Change in Cash | -84.96% | 402.83% | 243.51% | 153.97% | 147.06% |